For the year ended December 31, 2007, the net loss was $118,000, or $0.01 per share basic and diluted, compared with net loss of $481,000, or $0.03 per share basic and diluted for the same period in 2006.
Robert Bishop, CEO of AutoImmune, said: “Product sales at Colloral, our joint venture with Deseret Laboratories, were up from the third quarter, but results were down compared to the fourth quarter of last year.”